Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0114415001
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Dormant | 02225972 | APOTEX INC | APO-TEMAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | TEMAZEPAM | 30 MG |
Cancelled Post Market | 02244815 | COBALT PHARMACEUTICALS COMPANY | CO TEMAZEPAM CAPSULES 30MG | Human | Yes | Targeted (CDSA IV) | 1 | TEMAZEPAM | 30 MG |
Cancelled Post Market | 02229758 | DOMINION PHARMACAL | DOM-TEMAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | TEMAZEPAM | 30 MG |
Cancelled Post Market | 02231616 | GENPHARM ULC | GEN-TEMAZEPAM 30MG | Human | No | Targeted (CDSA IV) | 1 | TEMAZEPAM | 30 MG |
Cancelled Pre Market | 02347873 | NT PHARMA CANADA LTD | NTP-TEMAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | TEMAZEPAM | 30 MG |
Cancelled (Unreturned Annual) | 02239072 | PENTAPHARM LTD. | PENTA-TEMAZEPAM CAPSULES | Human | No | Targeted (CDSA IV) | 1 | TEMAZEPAM | 30 MG / CAP |
Cancelled Post Market | 02297965 | PHARMEL INC | PHL-TEMAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | TEMAZEPAM | 30 MG |
Dormant | 02273047 | PHARMASCIENCE INC | PMS-TEMAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | TEMAZEPAM | 30 MG |
Cancelled Post Market | 02229456 | PHARMASCIENCE INC | PMS-TEMAZEPAM - 30MG | Human | No | Targeted (CDSA IV) | 1 | TEMAZEPAM | 30 MG |
Cancelled Post Market | 02243024 | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | RATIO-TEMAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | TEMAZEPAM | 30 MG |
Marketed | 00604461 | AA PHARMA INC | RESTORIL | Human | Yes | Targeted (CDSA IV) | 1 | TEMAZEPAM | 30 MG |
Approved | 02223589 | APOTEX INC | TEMAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | TEMAZEPAM | 30 MG |
Cancelled Post Market | 02229761 | PRO DOC LIMITEE | TEMAZEPAM-30 | Human | Yes | Targeted (CDSA IV) | 1 | TEMAZEPAM | 30 MG |
Cancelled Post Market | 02230102 | TEVA CANADA LIMITED | TEVA-TEMAZEPAM | Human | Yes | Targeted (CDSA IV) | 1 | TEMAZEPAM | 30 MG |
Application information
Related information
Contact us
Version 4.0.3